Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$16.95 - $27.04 $11.2 Million - $17.9 Million
-662,937 Reduced 43.67%
855,293 $23.1 Million
Q1 2024

May 15, 2024

BUY
$11.38 - $19.03 $939,396 - $1.57 Million
82,548 Added 5.75%
1,518,230 $27.8 Million
Q4 2023

Feb 14, 2024

BUY
$6.29 - $15.72 $32,204 - $80,486
5,120 Added 0.36%
1,435,682 $17.6 Million
Q3 2023

Nov 14, 2023

BUY
$14.99 - $32.65 $1.11 Million - $2.41 Million
73,799 Added 5.44%
1,430,562 $21.4 Million
Q2 2023

Aug 14, 2023

BUY
$29.76 - $46.14 $8.54 Million - $13.2 Million
287,024 Added 26.83%
1,356,763 $44.1 Million
Q1 2023

May 15, 2023

BUY
$38.09 - $57.79 $2.18 Million - $3.31 Million
57,216 Added 5.65%
1,069,739 $41.9 Million
Q4 2022

Feb 14, 2023

SELL
$40.54 - $56.2 $1.41 Million - $1.96 Million
-34,833 Reduced 3.33%
1,012,523 $53.5 Million
Q3 2022

Nov 14, 2022

BUY
$36.98 - $49.2 $2,588 - $3,444
70 Added 0.01%
1,047,356 $47.1 Million
Q2 2022

Aug 11, 2022

BUY
$28.03 - $45.8 $48,183 - $78,730
1,719 Added 0.16%
1,047,286 $38.1 Million
Q1 2022

May 13, 2022

BUY
$29.24 - $44.06 $2.72 Million - $4.1 Million
93,134 Added 9.78%
1,045,567 $43.2 Million
Q4 2021

Feb 10, 2022

BUY
$39.32 - $61.61 $6.71 Million - $10.5 Million
170,773 Added 21.85%
952,433 $40.6 Million
Q3 2021

Nov 12, 2021

SELL
$44.0 - $65.8 $22.5 Million - $33.7 Million
-512,099 Reduced 39.58%
781,660 $43 Million
Q2 2021

Aug 12, 2021

BUY
$44.66 - $63.06 $6.02 Million - $8.5 Million
134,835 Added 11.63%
1,293,759 $61.9 Million
Q1 2021

May 12, 2021

BUY
$46.31 - $62.7 $36.4 Million - $49.3 Million
786,034 Added 210.8%
1,158,924 $58.7 Million
Q4 2020

Feb 16, 2021

BUY
$55.51 - $69.94 $4.01 Million - $5.05 Million
72,271 Added 24.04%
372,890 $23.5 Million
Q3 2020

Nov 16, 2020

BUY
$42.19 - $69.61 $2.33 Million - $3.85 Million
55,281 Added 22.53%
300,619 $20.2 Million
Q2 2020

Aug 13, 2020

BUY
$27.55 - $43.28 $1.4 Million - $2.2 Million
50,755 Added 26.08%
245,338 $10.3 Million
Q1 2020

May 14, 2020

BUY
$23.16 - $47.8 $247,510 - $510,838
10,687 Added 5.81%
194,583 $6.13 Million
Q4 2019

Feb 14, 2020

BUY
$27.97 - $40.38 $1.45 Million - $2.1 Million
51,942 Added 39.36%
183,896 $7.43 Million
Q3 2019

Nov 14, 2019

BUY
$31.65 - $46.94 $162,807 - $241,459
5,144 Added 4.06%
131,954 $4.29 Million
Q2 2019

Aug 14, 2019

BUY
$32.5 - $49.12 $4.12 Million - $6.23 Million
126,810 New
126,810 $6.15 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.